Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Generation and function of the soluble interleukin-6 receptor.

Müllberg J ¹,

Affiliations

1. Medizinische Klinik, Abteilung Pathophysiologie, Johannes Gutenberg Universität Mainz, Germany.
Authors
Müllberg J¹
(1 author)

ORCIDs linked to this article

Rose-John S | 0000-0002-7519-3279

Biochemical Society Transactions, 01 Feb 1999, 27(2):211-219
https://doi.org/10.1042/bst0270211 PMID: 10093736

Review

Abstract

No abstract provided.

Full text links

Read article at publisher's site: https://doi.org/10.1042/bst0270211

Subscription required at www.biochemsoctrans.org
http://www.biochemsoctrans.org/bst/027/0211/bst0270211.htm

Subscription required at www.biochemsoctrans.org
http://www.biochemsoctrans.org/bst/027/bst0270211.htm

Citations & impact

Impact metrics

16

Citations

Jump to Citations

Citations of article over time

Article citations

Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.
Bahari Z, Jangravi Z, Ghoshooni H, Afarinesh MR, Meftahi GH
Inflamm Res, 70(4):389-405, 19 Feb 2021
Cited by: 5 articles | PMID: 33608746 | PMCID: PMC7894237
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.
Magro G
Cytokine X, 2(2):100029, 14 May 2020
Cited by: 128 articles | PMID: 32421092 | PMCID: PMC7224649
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
IL-6 regulation of synaptic function in the CNS.
Gruol DL
Neuropharmacology, 96(pt a):42-54, 22 Nov 2014
Cited by: 109 articles | PMID: 25445486 | PMCID: PMC4446251
Free full text in Europe PMC
Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.
Campbell IL, Erta M, Lim SL, Frausto R, May U, Rose-John S, Scheller J, Hidalgo J
J Neurosci, 34(7):2503-2513, 01 Feb 2014
Cited by: 138 articles | PMID: 24523541 | PMCID: PMC6802757
Free full text in Europe PMC
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q
Carcinogenesis, 32(7):1013-1024, 23 Apr 2011
Cited by: 61 articles | PMID: 21515913 | PMCID: PMC3128561
Free full text in Europe PMC

Go to all (16) article citations

Similar Articles

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Interleukin-6 receptor shedding: a possible role for members of the ADAM family.
Croucher PI, Wang F, Hargreaves PG
Biochem Soc Trans, 27(2):224-228, 01 Feb 1999
Cited by: 6 articles | PMID: 10093738
Review
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, Wilkinson TS, Yamamoto N, Topley N, Jones SA
J Immunol, 172(9):5676-5683, 01 May 2004
Cited by: 75 articles | PMID: 15100312
[Hyper-IL-6 and liver diseases].
Qie CH, Qin B
Zhonghua Gan Zang Bing Za Zhi, 14(3):238-240, 01 Mar 2006
Cited by: 0 articles | PMID: 16556432
Review
Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptor.
Nawrocki S, Łaciak M, Izycki D, Gryska K, Wysocki PJ, Grabarczyk P, Karczewska A, Kaczmarek A, Murawa P, Malicki J, Rose-John S, Mackiewicz A
Adv Exp Med Biol, 495:411-418, 01 Jan 2001
Cited by: 2 articles | PMID: 11774603